Protagonist Therapeutics, Inc (PTGX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for PTGX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 10,307,837 | $1.3B | INCREASED |
| Vanguard | 7,019,174 | $860M | INCREASED |
| Farallon Capital Management | 6,348,906 | $778M | UNCHANGED |
| Rtw Investments | 5,061,175 | $620M | INCREASED |
| UBS Group | 3,506,315 | $430M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| PATEL DINESH V PH D (President and CEO) | EXERCISE | 7,278 | $157K | 2026-09-08 |
| PATEL DINESH V PH D (President and CEO) | EXERCISE | 63,548 | $1M | 2026-09-08 |
| PATEL DINESH V PH D (President and CEO) | EXERCISE | 54,174 | $1M | 2026-09-08 |
| PATEL DINESH V PH D (President and CEO) | SELL | 7,278 | $1M | 2026-09-08 |
| PATEL DINESH V PH D (President and CEO) | SELL | 63,548 | $9M | 2026-09-08 |
Full institutional holdings, insider history, and congressional trades for Protagonist Therapeutics, Inc on SentiSense.